Form DEFA14A Nuo Therapeutics, Inc.

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

 

Filed by the Registrant ☒

Filed by a party other than the Registrant ☐

 

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))

☐	Definitive Proxy Statement

☒	Definitive Additional Materials

☐	Soliciting Material Pursuant to Section 240.14a-12

 

 

NUO THERAPEUTICS, INC.

(Name of Registrant as Specified in Its Charter)

 

 

Payment of Filing Fee (Check all boxes that apply):

☒	No Fee Required

☐	Fee paid previously with preliminary materials

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Scalare Partners Brings Fishburners Pitch Night to Open Summit AI Adelaide in Search of Australia's Next Standout AI Companies
• Solana (SOL) Price Prediction: SOL Near $100.54 as Alpenglow Takes Focus and Remittix Plans a 64.3% Presale Price Rise
• BNB Price Prediction: Can BNB Reach $850 as Remittix Prepares Its $0.46 Final Presale Stage?